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Introduction
Patient safety efforts are often recommended solely on
judgments about the relative importance of particular
adverse events in hospital care, without considering the
frequency and costs of all hospital-acquired illness and
injury. The objective of the study was to use patient-level
cost data to estimate relative economic priorities for hos-
pital inpatient safety efforts.
Methods
Patient level costs are estimated using computerized
patient costing systems that initially log individual utiliza-
tion of inpatient services, and then apply sophisticated
cost estimates from the hospital's general ledger. The
occurrence of a hospital-acquired diagnosis is identified
using a new Australian 'condition-onset' flag for all diag-
noses not present on admission. These diagnoses are
grouped to yield a comprehensive set of 144 categories of
hospital-acquired conditions, using a recently-developed
algorithm to summarize data coded with ICD-10-AM.
Standard linear regression techniques are used to identify
the independent contribution to inpatient costs of hospi-
tal-acquired conditions, taking into account the case mix
of a sample of acute inpatients (n = 1,699,997) treated in
Australian public hospitals in Victoria (2005/06) and
Queensland (2006/07).
Results
The most costly types of adverse events were post-proce-
dure endocrine and metabolic disorders, adding $A
21,869 to the cost of an episode, followed by (methicillin-
resistant staphylococcus aureus) MRSA (+$A 19,892) and
enterocolitis due to Clostridium difficile (+$A 19,745).
Aggregate additional costs to the system were highest for
septicaemia (+$A 41.5 mil), complications of cardiac and
vascular implants other than septicaemia (+$A 28.7 mil),
acute lower respiratory infections -- including influenza
and pneumonia ($A 28.0 mil) -- and UTI (+$A 24.7 mil).
Hospital acquired complications are estimated to add
17.1% to the costs of treatment in this sample.
Conclusion
Patient safety efforts frequently focus on dramatic but rare
complications with very serious patient harms. Adding an
economic dimension to priority-setting could result in
changes to the priorities of patient safety programs. It
could also provide guidance as to other areas where
research into causes and prevention strategies may prove
a productive investment. Financial information should be
combined with information on patient harms to allow for
cost-utility evaluation of future programs.
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